Myron Schwarz

11PUBLICATIONS
98CO-AUTHORS
Innate immunityFormal methods for softwareCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

|Aug 25, 2025
Multiparametric cellular and spatial organization in cancer tissue lesions with a streamlined pipeline.

Mark Buckup, Igor Figueiredo, Giorgio Ioannou

|Feb 29, 2024
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.

Josep M Llovet, Roser Pinyol, Mark Yarchoan

|Jun 15, 2023
Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma.

Assaf Magen, Pauline Hamon, Nathalie Fiaschi

|Jun 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.

Naoto Fujiwara, Naoto Kubota, Emilie Crouchet

|Dec 15, 2021
Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies.

Masatoshi Kudo, Robert Montal, Richard S Finn

Pageof 2

Frequent Collaborators

5 joint publications

Josep M Llovet

4 joint publications

Thomas U Marron

3 joint publications

Sacha Gnjatic

3 joint publications

Miriam Merad